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Abstract: Niacinamide (NIA) is the amide form of vitamin B3 and has been widely used in
pharmaceutical and personal care formulations. Previously, we reported a comparative study of
NIA permeation from neat solvents using the Skin Parallel Artificial Membrane Permeability Assay
(PAMPA) and mammalian skin. A good correlation between NIA permeation in the different models
was found. In the present work, ten binary and ternary systems were evaluated for their ability to
promote NIA delivery in the Skin PAMPA model, porcine skin and human epidermis. Penetration
enhancement was evident for binary systems composed of propylene glycol and fatty acids in
human skin studies. However, propylene glycol and oleic acid did not promote enhancement of
NIA compared with other systems in the Skin PAMPA model. A good correlation was obtained
for permeation data from Skin PAMPA and porcine skin. However, data from the Skin PAMPA
model and from human skin could only be correlated when the PG-fatty acid systems were excluded.
These findings add to our knowledge of the potential applications of Skin PAMPA for screening
dermal/transdermal preparations.
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1. Introduction
Niacinamide (NIA) is the water-soluble form of vitamin B3 (Figure 1). Since its discovery as
a “pellagra-preventing” agent, this molecule has been widely used in personal care and cosmetic
products [1,2]. NIA has been demonstrated to have a number of anti-inflammatory and photo-protective
effects following topical application. The therapeutic benefits of NIA in the management of acne and
atopic dermatitis and promotion of the up-regulation of epidermal lipid synthesis have also been
reported [3,4]. Mohammed, et al. [5] investigated the influence of NIA on the molecular properties of
the human stratum corneum (SC) in vivo. The authors assessed the corneocyte maturity and surface
area from NIA treated and untreated (control) areas, as well as trans-epidermal water loss (TEWL).
The thickness of the SC before and after the application of NIA was determined using confocal Raman
spectroscopy (CRS). The NIA treatment decreased TEWL values, increased the thickness of the SC,
and larger and more mature corneocytes were found in the treated versus control sites. More recently,
evidence from a phase 3 randomized clinical trial points to NIA having a role in the prevention of
non-melanoma skin cancer [6,7].
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Figure 1. The 2D structure of niacinamide. 
The discovery and development of robust and accessible human skin surrogates continues to be 
an area of considerable interest to industry and regulatory authorities. Recently, we reported the use 
of the Skin Parallel Arterial Membrane Permeability Assay (PAMPA) model to assess in vitro 
permeation of NIA from a number of solvents, namely, propylene glycol (PG), dimethyl isosorbide 
(DMI), Transcutol® P (TC), t-butyl alcohol (T-BA), PEG 400, PEG 600, and a commercial product 
containing NIA [8]. In vitro permeation studies were also performed using porcine skin and heat-
separated human epidermis. The permeation studies were conducted under finite dose conditions, 
namely, 5 μL/cm2 for human/pig skin and 3 μL/cm2 for the Skin PAMPA model. When the permeation 
data for the models were compared, a correlation coefficient (R2) of 0.71 for human skin and PAMPA 
was obtained and the corresponding correlation coefficient for porcine skin and PAMPA was 0.88. 
A number of studies have reported that combinations of vehicles and/or chemical penetration 
enhancers may improve skin uptake and the permeation of actives in a synergistic manner [9,10]. PG 
is one of the most commonly used glycols in skin preparations [11]. The synergistic enhancement of 
drug delivery to the skin was reported when PG was employed as a co-solvent in delivery systems 
[12]. In our previous work, a range of neat solvents were evaluated for NIA skin delivery; both PG 
and TC were identified as the most promising vehicles for this active [8]. The primary aim of the 
present work was to examine the efficacy of combinations of PG or TC with other solvents on the 
skin uptake of NIA. The solvents selected were T-BA, DMI, oleic acid (OA), linolenic acid (LA) and 
caprylic/capric triglyceride (CCT). These solvents were selected as they encompass varying 
physicochemical properties and, where known, different mechanisms of skin penetration 
enhancement [11,13]. A secondary aim was to further explore the feasibility of the Skin PAMPA for 
screening multi-component formulations. 
2. Materials and Methods 
2.1. Materials 
NIA, PG, T-BA, OA, LA, high-performance liquid chromatography (HPLC) grade water and 
methanol, were purchased from Sigma-Aldrich, Dorset, UK. DMI and IPM were supplied from Croda 
Ltd., Goole, UK. TC and CCT were kind donations from Gattefossé, St. Priest, France. Phosphate 
buffered saline (PBS) (pH 7.3 ± 0.2 at 25 °C) tablets was supplied by Oxoid, Cheshire, UK. Pre-coated 
PAMPA Plates (Pion Inc. PN120657), hydration solution, stirring disks and a Gut-Box™ device were 
obtained from pION Inc. Billerica, MA, USA. 
2.2. Miscibility and Stability Studies 
Miscibility studies of all vehicles were conducted to identify appropriate combinations of 
solvents for binary and ternary systems. The stability of NIA at a concentration of 5% (w/v) in PG:T-
BA (90:10), PG:OA (10:90), PG:TC (50:50), PG:DMI (50:50), PG:LA (50:50), PG:TC:DMI (50:25:25), TC: 
T-BA (90:10) and TC:DMI (50:50), TC:CCT:DMI (50:25:25) and TC:PG:DMI (50:25:25) was examined 
at 32 ± 1 °C up to 72 h [14]. The concentration of NIA was determined at 0, 24, 48 and 72 h. Samples 
were analyzed using the HPLC method validated earlier with a Kinetix® 5 mm Phenyl-Hexyl 250 × 
4.6 mm reversed column (Phenomenex, Macclesfield, UK) with water:methanol (80:20) as the mobile 
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The discovery and development of robust and accessible human skin surrogates continues to be an
area of considerable interest to industry and regulatory authorities. Recently, we reported the use of the
Skin Parallel Arterial Membrane Permeability Assay (PAMPA) model to assess in vitro permeation of
NIA from a number of solvents, namely, propylene glycol (PG), dimethyl isosorbide (DMI), Transcutol®
P (TC), t-butyl alcohol (T-BA), PEG 400, PEG 600, and a commercial product containing NIA [8]. In vitro
permeation studies were also performed using porcine skin and heat-separated human epidermis.
The permeation studies were conducted under finite dose conditions, namely, 5 µL/cm2 for human/pig
skin and 3 µL/cm2 for the Skin PAMPA model. When the permeation data for the models were
compared, a correlation coefficient (R2) of 0.71 for human skin and PAMPA was obtained and the
corresponding correlation coefficient for porcine skin and PAMPA was 0.88.
A number of studies have reported that combinations of vehicles and/or chemical penetration
enhancers may improve skin uptake and the permeation of actives in a synergistic manner [9,10]. PG is
one of the most commonly used glycols in skin preparations [11]. The synergistic enhancement of drug
delivery to the skin was reported when PG was employed as a co-solvent in delivery systems [12].
In our previous work, a range of neat solvents were evaluated for NIA skin delivery; both PG and TC
were identified as the most promising vehicles for this active [8]. The primary aim of the present work
was to examine the efficacy of combinations of PG or TC with other solvents on the skin uptake of
NIA. The solvents selected were T-BA, DMI, oleic acid (OA), linolenic acid (LA) and caprylic/capric
triglyceride (CCT). These solvents were selected as they encompass varying physicochemical properties
and, where known, different mechanisms of skin penetration enhancement [11,13]. A secondary aim
was to further explore the feasibility of the Skin PAMPA for screening multi-component formulations.
2. Materials and Methods
2.1. Materials
NIA, PG, T-BA, OA, LA, high-performance liquid chromatography (HPLC) grade water and
methanol, were purchased from Sigma-Aldrich, Dorset, UK. DMI and IPM were supplied from
Croda Ltd., Goole, UK. TC and CCT were kind donations from Gattefossé, St. Priest, France.
Phosphate buffered saline (PBS) (pH 7.3 ± 0.2 at 25 ◦C) tablets was supplied by Oxoid, Cheshire, UK.
Pre-coated PAMPA Plates (Pion Inc. PN120657), hydration solution, stirring disks and a Gut-Box™
device were obtained from pION Inc. Billerica, MA, USA.
2.2. Miscibility and Stability Studies
Miscibility studies of all vehicles were conducted to identify appropriate combinations of solvents
for binary and ternary systems. The stability of NIA at a concentration of 5% (w/v) in PG:T-BA (90:10),
PG:OA (10:90), PG:TC (50:50), PG:DMI (50:50), PG:LA (50:50), PG:TC:DMI (50:25:25), TC: T-BA (90:10)
and TC:DMI (50:50), TC:CCT:DMI (50:25:25) and TC:PG:DMI (50:25:25) was examined at 32 ± 1 ◦C
up to 72 h [14]. The concentration of NIA was determined at 0, 24, 48 and 72 h. Samples were
analyzed using the HPLC method validated earlier with a Kinetix® 5 mm Phenyl-Hexyl 250 × 4.6 mm
reversed column (Phenomenex, Macclesfield, UK) with water:methanol (80:20) as the mobile phase.
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The injection volume was set at 10 µL, and the flow rate of the mobile phase was set to 1 mL/min.
The column temperature was set to 30 ◦C and the UV detection wavelength was 263 nm [8].
2.3. The Skin PAMPA Permeation Studies
The influence of binary and ternary solvent systems on the permeation of NIA was initially
screened using the Skin PAMPA model. The Skin PAMPA model was hydrated and prepared following
the procedure described by Luo, et al. [15]. The permeation studies were conducted using a modified
protocol described previously [8]. A dose of 1 µL (corresponding to 3 µL/cm2) was used, as it was
shown to represent a finite dose of NIA formulations in previous Skin PAMPA studies. To maintain the
temperature of the membrane at 32 ± 1 ◦C, the Skin PAMPA apparatus was incubated in a “Gut-Box™”
chamber during the course of permeation studies. Freshly prepared and degassed phosphate buffered
saline (PBS, pH 7.3 ± 0.2) solution served as the receptor medium. Samples were collected at 0.1, 0.2,
0.3, 0.7 1, 1.5, 2 and 2.5 h. The concentration of NIA in the receptor medium at each interval was
quantified using the HPLC method validated previously [8].
2.4. Permeation Studies in Porcine and Human Skin
Vertical glass Franz diffusion cells were used to conduct in vitro permeation studies of NIA in
full thickness porcine and heat-separated human skin, as reported previously [16,17]. All permeation
studies were conducted under finite dose conditions (5 µL/cm2). Porcine tissue was obtained from a
local abattoir. The human (female, Caucasian) abdominal tissue from three donors following plastic
surgery was obtained from a tissue bank with institutional approval (Research Ethics Committee
reference 07/H1306/98). Porcine and human tissue membranes with a diffusion area of around 1 cm2
were prepared following the procedures described earlier, and the membrane integrity was examined
by a measurement of electrical resistance [8]. The Franz cells were placed into a thermostatically
controlled water bath (JB Nova, Grant, Cambridge, UK) set at 36 ± 1 ◦C during the course of the
permeation studies. The NIA formulations were applied to the skin when the temperature of the skin
surface had equilibrated to 32 ± 1 ◦C (TM-22 Digitron digital thermometer, RS Components, Corby,
UK). A total of 200 µL of receptor medium was withdrawn and replaced with an equal volume of PBS
solution at each sampling interval: 0, 1, 2, 4, 6, 8, 10, 12 and 24 h. At the end of the permeation studies,
the receptor phase was removed, and mass balance evaluation was performed following a procedure
validated previously [18]. The mass balance method is described in the Supplementary Materials.
2.5. Data Analysis
Data were recorded using Microsoft® Excel and analyzed using SPSS® Statistics version 24
(IBM, Feltham, UK) using the procedure described previously [8]. One-way ANOVA with a post
hoc Tukey Test was performed for data that met the assumption of normality and homogeneity of
variance. The Kruskal–Wallis H Test was used for non-parametric data. A p-value of <0.05 was
considered as a statistically significant difference. The correlation between the cumulative amounts of
NIA that permeated in the Skin PAMPA model and mammalian skin was calculated using the Pearson
Product–moment correlation coefficient (R2) in Microsoft® Excel.
3. Results and Discussion
3.1. Stability Determination
The stability of NIA in the seven binary and three ternary systems was confirmed. After 72 h,
the recovery values of NIA in all tested systems were greater than 91.0%. The stability of NIA in the
receptor medium, PBS solution, was confirmed in our earlier work [8]. Stability results are reported in
the Supplementary Materials (Figure S1).
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3.2. Skin PAMPA Permeation Studies
Figure 2A shows the permeation profiles of NIA for PG:T-BA (90:10), PG:OA (10:90), PG:TC
(50:50), PG:DMI (50:50), PG:LA (50:50) and PG:TC:DMI (50:25:25) in the Skin PAMPA model. At 2.5 h,
the cumulative amounts of NIA that permeated through the membrane ranged from 44.2 to 177.4µg/cm2.
PG:T-BA was the most efficient system for NIA delivery compared with all other PG binary or ternary
systems (p < 0.05). The cumulative amount of NIA delivered through the Skin PAMPA model from
neat PG was determined as 163.1 µg/cm2 [8]. No difference was evident when comparing NIA
permeation from PG:T-BA (90:10) and neat PG (p > 0.05). The amount of NIA delivered by PG:OA
(10:90), 140.2 ± 18.9 µg/cm2, was significantly greater than corresponding values for PG:TC (50:50),
PG:DMI (50:50) and PG:LA (50:50) (p < 0.05). The ternary system composed of PG, TC and DMI did
not enhance the permeation of NIA in Skin PAMPA compared with PG:DMI (50:50) and PG:TC (50:50)
(p > 0.05). A significantly lower permeation of NIA was observed for PG:LA (50:50), 44.2 ± 9.4 µg/cm2,
compared with all other binary and ternary systems and neat PG (p< 0.05). Formulations containing TC
and other solvents were subsequently assessed in the Skin PAMPA model under finite dose conditions
(Figure 2B). At 2.5 h, the cumulative amounts of NIA that permeated from TC:T-BA (90:10) and
TC:DMI (50:50) were 160.0 ± 8.5 and 159.9 ± 5.4 µg/cm2, respectively (p > 0.05). The amounts of NIA
that permeated from TC:T-BA (90:10) and TC:DMI (50:50) were significantly higher compared with
corresponding values for TC:CCT:DMI (50:25:25) and TC:PG:DMI (50:25:25) (p < 0.05).
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Figure 2. Cumulative permeation of niacinamide (NIA) from binary and ternary solvent systems
composed of propylene glycol (PG): t-butyl alcohol (T-BA) (), PG: oleic acid (OA) (), PG: Transcutol®
P (TC) (
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Transcutol®   ◆), PG: dimethyl isosorbide (DMI) (▲), PG: linolenic acid (LA) (▄), PG:TC:DMI 
(50:25:25, ●) (A), TC:T-BA(●), TC:DMI(■), TC:PG:DMI (50:25:25, ■) and TC: caprylic/capric 
triglyceride (CCT):DMI (50:25:25, ◆) (B) in the Skin PAMPA model following the application of 1μL 
per well (corresponding to 3 μL/cm2) of formulations. Each data point represents the mean ± SD, n = 
4. ⁕ p < 0.05. 
Table 1 summarizes the percentages of NIA permeation from the binary and ternary systems. 
At 2.5 h, for PG:OA (10:90), PG:T-BA (90:10), PG:TC:DMI (50:25:25), TC:DMI (50:50) and TC:T-BA 
(90:10), more than 80% of the applied active was delivered into the receptor phase (p > 0.05). In the 
previous study, the cumulative amounts of NIA that permeated for neat TC and PG in the Skin 
PAMPA model were 184.7 ± 8.9 and 163.1 ± 1.1 μg/cm2, accounting for 97% and 95% of the applied 
amounts, respectively [8]. Compared with neat TC, the TC binary systems did not enhance the 
permeation of NIA in the Skin PAMPA model (p > 0.05). Interestingly, compared with neat PG, the 
permeation of NIA was enhanced for PG:T-BA (90:10) (p < 0.05). However, the permeation of NIA 
from PG:LA (50:50) was significantly lower than NIA permeation from neat PG (p < 0.05). 
Table 1. Percentage permeation of NIA from the binary systems in the Skin PAMPA model (n = 4, 
mean ± SD). 
Formulation Percentage Permeation (%) at 2.5 h 
PG:LA (50:50) 26.9 ± 5.7 
PG:DMI (50:50) 66.0 ± 6.9 
PG:TC (50:50) 68.0 ± 12.3 
PG:OA (10:90) 95.2 ± 13.8 
PG:T-BA (90:10) 103.7 ± 0.5 
TC:T-BA (90:10) 97.3 ± 5.1 
TC:DMI (50:50) 97.2 ± 3.3 
TC:PG:DMI (50:25:25) 77.5 ± 8.2 
TC:CCT:DMI (50:25:25) 75.3 ± 4.9 
TC:CCT:DMI (50:25:25) 81.2 ± 3.2 
3.3. Porcine Skin Permeation and Mass Balance Studies 
The various binary and ternary solvent systems were examined for their influence on NIA 
permeation using porcine skin under finite dose conditions (5 μL/cm2). Figure 3A and Figure 3B show 
the permeation profiles for the binary formulations composed of PG or TC. For PG:T-BA (90:10), NIA 
permeation was detected after 1 h and this system delivered a significantly higher amount of NIA 
through the tissue compared with other formulations, namely, 150.3 ± 26.5 μg/cm2 at 24 h (p < 0.05). 
The cumulative amounts of NIA that permeated from PG:OA (10:90) and PG:TC:DMI (50:25:25) were 
70.2 ± 18.1 and 58.4 ± 7.0 μg/cm2, respectively (p > 0.05). The cumulative permeation of NIA from PG: 
LA (50:50) was 19.3 ± 13.7 μg/cm2, a value that was significantly lower than PG:T-BA (90:10). The 
amounts of NIA that permeated through porcine skin from binary and ternary formulations of TC 
ranged from 34.1 to 178.0 μg/cm2 (Figure 3B). The cumulative amounts of NIA that permeated from 
neat TC and PG were previously reported as 95.1 and 46.0 μg/cm2 in pig skin, respectively [8]. At 24 
h, a higher cumulative permeation of NIA was evident for TC:T-BA (90:10) compared with neat TC 
or other assessed binary and ternary systems containing TC (p < 0.05). 
N), PG: linolenic acid (L ) (
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Table 1 summarizes the percentages of NIA permeation from the binary and ternary systems.
At 2.5 h, for PG:OA (10:90), PG:T-BA (90:10), PG:TC:DMI (50:25:25), TC:DMI (50:50) and TC:T-BA
(90:10), more than 80% of the applied active was delivered into the receptor phase (p > 0.05). In the
previous study, the cumulative amounts of NIA that permeated for neat TC and PG in the Skin PAMPA
model were 184.7 ± 8.9 and 163.1 ± 1.1 µg/cm2, accounting for 97% and 95% of the applied amounts,
respectively [8]. Compared with neat TC, the TC binary systems did not enhance the permeation of
NIA in the Skin PAMPA model (p > 0.05). Interestingly, compared with neat PG, the permeation of
NIA was enhanced for PG:T-BA (90:10) (p < 0.05). However, the permeation of NIA from PG:LA (50:50)
was significantly lower than NIA permeation from neat PG (p < 0.05).
Table 1. Percentage permeation of NIA from the binary systems in the Skin PAMPA model (n = 4,
mean ± SD).
Formulation Percentage Permeation (%) at 2.5 h
PG:LA (50:50) 26.9 ± 5.7
PG:DMI (50:50) 66.0 ± 6.9
PG:TC (50:50) 68.0 ± 12.3
PG:OA (10:90) 95.2 ± 13.8
PG:T-BA (90:10) 103.7 ± 0.5
TC:T-BA (90:10) 97.3 ± 5.1
TC:DMI (50:50) 97.2 ± 3.3
TC:PG:DMI (50:25:25) 77.5 ± 8.2
TC:CCT:DMI (50:25:25) 75.3 ± 4.9
TC:CCT:DMI (50:25:25) 81.2 ± 3.2
3.3. Porcine Skin Permeation and Mass Balance Studies
The various binary and ternary solvent systems were examined for their influence on NIA
permeation using porcine skin under finite dose conditions (5µL/cm2). Figure 3A,B show the permeation
profiles for the binary formulations composed of PG or TC. For PG:T-BA (90:10), NIA permeation was
detected after 1 h and this system delivered a significantly higher amount of NIA through the tissue
compared with other formulations, namely, 150.3 ± 26.5 µg/cm2 at 24 h (p < 0.05). The cumulative
amounts of NIA that permeated from PG:OA (10:90) and PG:TC:DMI (50:25:25) were 70.2 ± 18.1 and
58.4 ± 7.0 µg/cm2, respectively (p > 0.05). The cumulative permeation of NIA from PG: LA (50:50) was
19.3 ± 13.7 µg/cm2, a value that was significantly lower than PG:T-BA (90:10). The amounts of NIA
that permeated through porcine skin from binary and ternary formulations of TC ranged from 34.1 to
178.0 µg/cm2 (Figure 3B). The cumulative amounts of NIA that permeated from neat TC and PG were
previously reported as 95.1 and 46.0 µg/cm2 in pig skin, respectively [8]. At 24 h, a higher cumulative
permeation of NIA was evident for TC:T-BA (90:10) compared with neat TC or other assessed binary
and ternary systems containing TC (p < 0.05).
The overall recoveries in the mass balance studies for PG:OA (10:90), PG:DMI (50:50), PG:TC
(50:50), TC:DMI (50:50) and PG:TC:DMI were <85% (Table 2). These results are consistent with the
findings of Haque et al. [18]. As the stability of NIA in all formulations was confirmed, it is possible
that the lower recovery might be attributed to the chemical derivatization of this molecule during the
permeation process [19]. The higher total recovery in binary TC-T-BA systems may reflect the potential
of TC:T-BA (90:10) to prevent the chemical derivatization of NIA. However, this hypothesis needs to
be probed further. For PG:T-BA (90:10) and TC:T-BA (90:10), lower percentages of NIA were recovered
from the skin surface compared with all other binary and ternary systems, accounting for 3.5% and
6.1% of applied NIA amounts, respectively (p < 0.05). After 24 h, for all formulations, skin extraction
values ranged from 3.2% to 32.9% of the applied amounts. PG:TC (50:50) significantly increased the
percentage of NIA deposited in porcine skin compared with neat PG (p < 0.05), while no difference was
detected when compared with TC (p > 0.05). The skin retention values observed for the three tested
ternary systems were not significantly different (p > 0.05). Interestingly, comparing the distribution of
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NIA in the tissue for binary and ternary systems, a higher skin retention was evident for TC:CCT:DMI
(50:25:25) than for TC:DMI (50:50) (p < 0.05). CCT is a triglyceride comprising a mixture of caprylic and
capric acid esters and has been widely used in cosmetic products as an emollient [20]. Leopold and
Lippold [21] investigated the mechanism of the penetration enhancing effects of several lipophilic
vehicles including CCT using Differential Scanning Calorimetry (DSC). These authors suggested that
any penetration enhancement effects of CCT are probably caused by the dissolution or extraction of
the stratum corneum lipids. The systems composed of CCT examined here appear promising for the
dermal delivery of NIA, and these formulations were further evaluated using human skin.Pharmaceutics 2019, 11, x FOR PEER REVIEW 6 of 13 
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Table 2. The results of the mass balance studies after the permeation studies using porcine skin under
finite dose conditions (n = 4, mean ± SD).
Formulation Washing % Extraction % Permeation % Total %
PG:DMI (50:50) 47.1 ± 5.4 22.9 ± 13.2 11.5 ± 3.9 81.5 ± 5.6
PG:OA (10:90) 37.1 ± 5.4 9.6 ± 1.0 30.2 ± 7.2 76.8 ± 5.9
PG:TC (50:50) 43.4 ± 3.9 23.4 ± 5.6 13.4 ± 6.9 80.2 ± 6.7
PG:LA (50:50) 55.6 ± 12.3 20.6 ± 4.4 9.2 ± 6.6 85.4 ± 7.9
PG:T-BA (90:10) 3.5 ± 0.8 10.1 ± 7.6 71.3 ± 12.6 84.9 ± 7.1
TC:T-BA (90:10) 6.1 ± 5.2 15.3 ± 11.9 79.5 ± 12.0 100.9 ± 13.8
TC:DMI (50:50) 35.3 ± 13.6 10.7 ± 3.5 35.2 ± 16.0 81.2 ± 1.8
PG:TC:DMI (50:25:25) 36.1 ± 8.5 18.8 ± 8.8 25.1 ± 3.8 80.1 ± 9.7
TC:CCT:DMI (50:25:25) 39.8 ± 15.1 28.0 ± 12.8 18.2 ± 7.6 86.0 ± 8.9
TC:PG:DMI (50:25:25) 43.2 ± 4.0 32.9 ± 13.8 13.2 ± 1.9 89.2 ± 16.8
As shown in Figure 4, 19.3–178.0 µg/cm2 of NIA penetrated through porcine skin at 24 h,
while 44.2–177.4 µg/cm2 was delivered in the Skin PAMPA model at 2.5 h. A correlation coefficient (R2)
of 0.63 was determined for the linear regression of the data (Figure 4). The value was lower compared
with the correlation coefficient determined between the permeation data in Skin PAMPA and porcine
skin for the single solvents under finite dose conditions, R2 = 0.88 [8]. This may reflect the different
interactions of the more complex vehicles studied here in the Skin PAMPA lipids compared with the
single solvents studied previously.
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3.4. Human Skin Permeation and Mass Balance Studies
NIA permeation was further investigated using heat-separated human epidermis. The permeation
profiles of NIA for these experiments are shown in Figure 5. For the two binary systems, PG:LA (50:50)
and PG:OA (10:90), permeation of NIA was detected 2 h after application. At 24 h, significantly higher
amounts of NIA were delivered from PG:LA (50:50) and PG:OA (10:90) compared with all other binary
and ternary systems (p < 0.05), with cumulative permeation values of 100.4 ± 2.4 and 93.3 ±2.4 µg/cm2,
respectively. The cumulative amounts of NIA that permeated in human skin for neat T-BA, DMI, PG or
TC were reported previously as 50.8, 15.0, 1.8 and 16.4 µg/cm2 [8]. A more efficient skin penetration
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enhancement of NIA is clearly evident for PG:LA and PG:OA compared with these neat solvents
(p < 0.05). No significant increase was observed for NIA permeation from TC binary and ternary
systems compared with neat TC (p > 0.05).
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Table 3 summarizes the mass balance results of NIA for the human skin studies. The amounts
of NIA remaining on the skin surface range from 27% to 75% of the amounts applied, respectively.
No difference was de ected comparin the percentage of NIA recover d from the skin surface for the
different f rmulations (p > 0.05). The skin retention of NIA for PG:LA (50:50) was determined as 3.4%
of the applie dos . This valu was signific ntly lower (p < 0.05) compared with the skin extraction
values or TC:T-BA (34.7%) and TC:CCT:DMI (29.7%). T p rc ntage of NIA extracted from human
epidermis for neat TC was 32.9% [8]. The corresponding value for TC:T-BA (90:10) was comp rabl to
the value for neat TC (p > 0.05). As for the percentage p rmeation, hig er values were observ d for
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PG:LA (50:50) (46.1%) and PG:OA (10:90) (40.7%) compared to all other binary and ternary systems
(p < 0.05). There was no significant increase in the percentage permeation of NIA from TC binary
systems compared with neat TC (p > 0.05). Statistical analysis confirmed the penetration enhancement
of NIA for the PG/fatty acids (LA and OA) compared with neat PG [8] (p < 0.05). However, in porcine
skin studies, the percentage permeation of NIA for PG:LA (50:50) was significantly lower than for neat
PG and PG:OA (10:90) (p < 0.05).
Table 3. The results of mass balance studies after permeation studies using human skin under finite
dose conditions (n = 4, mean ± SD).
Formulations Washing% Extraction% Permeation% Total%
PG:DMI (50:50) 59.6 ± 7.1 17.4 ± 3.9 5.6 ± 4.0 82.6 ± 7.8
PG:OA (10:90) 37.7 ± 6.7 9.2 ± 0.6 40.7 ± 6.5 87.6 ± 0.8
PG:TC (50:50) 69.8 ± 7.8 29.0 ± 18.5 4.4 ± 2.3 103.1 ± 13.4
PG:LA (50:50) 27.1 ± 5.6 3.4 ± 2.0 46.1 ± 5.1 76.5 ± 5.1
PG:T-BA (90:10) 52.8 ± 9.0 20.1 ± 6.0 12.3 ± 4.2 85.2 ± 10.9
TC:T-BA (90:10) 39.8 ± 16.5 34.7 ± 10.5 15.6 ± 5.6 90.1 ± 5.2
TC:DMI (50:50) 75.1 ± 11.7 13.2 ± 4.7 10.2 ± 4.4 98.5 ± 11.7
PG:TC:DMI (50:25:25) 64.6 ± 4.5 12.2 ± 2.0 6.2 ± 2.3 83.0 ± 4.2
TC:CCT:DMI (50:25:25) 44.9 ± 6.0 29.7 ± 4.9 12.9 ± 3.3 87.5 ± 4.9
TC:PG:DMI (50:25:25) 66.5 ± 9.1 14.6 ± 3.4 6.6 ± 2.5 87.8 ± 6.7
Fatty acids have been reported to be skin permeation enhancers for a range of substances
possessing varying physicochemical properties [11,22,23]. Recently, Pham, et al. [24] applied 13C
polarization transfer solid-state nuclear magnetic resonance (NMR) to investigate the effects of OA
on SC molecular components. The authors mixed 30 mg of dry SC powder with 5% of OA and
then hydrated the mixture with water. The samples were incubated at 32 ◦C for 24 h before NMR
measurement. It was suggested that OA promoted increased mobility of both stratum corneum protein
components and the cholesterol chain segments in the intercellular lipid domains. However, the exact
synergistic mechanism of PG and fatty acids remains unclear. It may also be hypothesized that the fatty
acid first penetrates into the stratum corneum and contributes to increased lipid fluidity, which allows
the diffusion of PG with dissolved NIA.
In the present study, there was no significant difference between the permeation in human skin
and porcine skin for NIA in TC:DMI (50:50) PG:DMI (50:50), TC:CCT:DMI (50:25:25) (p > 0.05). A higher
permeation of NIA in porcine skin compared to human skin was evident for PG:T-BA (90:10), PG:DMI
(50:50), PG:TC (50:50), PG:TC:DMI (50:25:25), TC:T-BA (90:10) and TC:PG:DMI (50:25:25) (p < 0.05).
However, a lower permeation of NIA in porcine skin compared to human tissue was evident for PG:LA
(50:50) and PG:OA (10:90) (p < 0.05). Similar results have been reported by other researchers for other
actives. Shin, et al. [25] noted higher flux values of fentanyl for human skin compared with porcine
skin. Although pig skin has generally been considered to be more permeable than human skin [26–28],
the permeability may be dependent on the molecule of interest. Jung and Maibach [29] reviewed 46
studies which evaluated the permeation of 77 chemicals using both porcine and human skin; for 16
chemicals, permeation was greater in human skin permeation compared with porcine skin.
The cumulative permeation of NIA in human skin ranged from 14.5 to 100.4 µg/cm2;
the corresponding values determined in the Skin PAMPA model ranged from 44.2 to 177.4 µg/cm2.
Higher NIA permeation was observed in the artificial membrane compared with human epidermis for
PG:T-BA (90:10), TC:T-BA (90:10), TC:DMI (50:50), PG:OA (10:90), PG:TC:DMI (50:25:25), TC:CCT:DMI
(50:25:25), PG:DMI (50:50) and PG:TC (50:50) (p < 0.05). Attempts to fit all the permeation data from
the Skin PAMPA model and human epidermis were not successful. However, excluding results for
PG:LA (50:50) and PG:OA (10:90), an R2 value of 0.68 was obtained for the linear regression of the data
(Figure 6). The higher permeability of the Skin PAMPA studies observed in this study is consistent
with findings reported by others. Luo et al. [15] investigated the permeation of ibuprofen from PG,
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PEG 300, commercial gel and spray formulations in the Skin PAMPA model, porcine and human skin.
The authors reported the more permeable nature of the Skin PAMPA model compared to human
skin. Although the authors did not correlate the permeation data obtained from different models,
they reported formulations that delivered a higher amount of ibuprofen in the Skin PAMPA model
were also more efficient in human skin. In our previous work, NIA permeation from neat T-BA, DMI,
TC, PG, PEG 400 and PEG 600 and one commercial product in the Skin PAMPA model were correlated
with porcine/human skin [8]. A correlation coefficient (R2) of 0.71 was established for the Skin PAMPA
with human skin under finite dose conditions. The corresponding correlation between PAMPA model
and porcine skin was determined as 0.88. In this work, a correlation of NIA permeation data in human
skin and PAMPA model could only be obtained when the permeation data for PG-OA and PG-LA
were excluded. Statistical analysis confirmed that the permeation of NIA from PG:LA (50:50) was
significantly lower than neat PG (p < 0.05) in the Skin PAMPA. Additionally, in the Skin PAMPA model,
the permeation of NIA from PG:OA (10:90) was significantly higher compared with PG:LA (50:50)
(p < 0.05), while no difference was observed between these two systems in human epidermis (p > 0.05).
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Figure 6. Cumulative permeation data of NIA from assessed binary and ternary solvent systems in the
Skin PAMP model at 2.5 h, plotted against the corresponding values observed in human skin at 24 h.
Each data point represents the mean ± SD, n = 4.
To our knowledge, this is the first study that has investigated the permeation enhancement of fatty
acids with PG in the Skin PAMPA model. The results obtained in this study suggested that the Skin
PAMPA model is not a suitable model for screening such combinations. The Skin PAMPA model uses a
homogeneous filter-impregnated lipid mixture membrane, containing ~50% of synthesized ceramides
(Certramide), 25% of stearic acid and 25% of cholesterol [30]. The lower permeation of binary solvent
systems composed of PG and fatty acid may reflect the interaction of the lipid components with those
formulations. Both OA and LA are unsaturated C18 fatty acids [31]. These two fatty acids have a
double bond in the conformation [32]. It is possible that OA and LA integrated into the PAMPA
membrane and modified the lateral chain packing in the lipid matrix. This may lead to changes in the
physicochemical properties and permeability of this artificial model. Further studies are needed to
probe this theory.
4. Conclusions
Previous work investigated the dermal delivery of NIA from a series of single solvents. In the
present work, the influence of binary and ternary solvents on the in vitro permeation of NIA was
assessed in the Skin PAMPA model, porcine skin and heat separated human epidermis. The higher
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skin penetration of NIA was evident in human skin for the binary systems composed of PG with fatty
acids (PG-OA, PG-LA) compared with neat solvents investigated previously. A correlation of 0.63
was determined for the permeation data of binary and ternary systems in Skin PAMPA and in porcine
skin. Excluding the PG-OA and PG-LA systems, a correlation of 0.68 (R2) was also evident between
the permeation data obtained in the Skin PAMPA model and human epidermis. Further studies to
investigate the interactions between the Skin PAMPA model and the fatty acids OA and LA are needed
to better understand the potential of this model in the assessment of transdermal/dermal products.
Ultimately, a robust, efficient, accessible artificial skin permeability assay would benefit the regulatory
authorities, the pharmaceutical industry and the patients.
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Figure S1: Results of stability studies. Percentage of NIA recovered from tested binary and ternary solvent systems
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